Form 4: Ducommun Director Sells $1.3M in Stock

Ducommun Inc. Director Richard A. Baldridge sold 10,440 shares of common stock for approximately $1.37 million on March 10, 2026, under a Rule 10b5-1 plan.

Summary

• Richard A. Baldridge, a Director of Ducommun Inc. (DCO), reported a sale of common stock.
• The transaction involved the disposition of 10,440 shares of common stock.
• The shares were sold on March 10, 2026, at a weighted average price of $130.83 per share.
• The total value of the shares sold was approximately $1,365,997.20.
• The sale was executed in multiple trades with prices ranging from $130.00 to $132.41.
• Following this transaction, Richard A. Baldridge beneficially owns 20,100 shares of Ducommun Inc. common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was executed under a pre-arranged Rule 10b5-1 plan, which typically indicates a planned liquidity event or portfolio diversification rather than a reaction to new material information about the company's performance.

Industry Context

StockSavvy.ai notes that insider sales, especially by directors, are routinely monitored by investors for potential signals regarding management's view of future company performance. However, sales executed under a Rule 10b5-1 plan are often pre-scheduled and may not reflect new discretionary insights into the company's immediate prospects.

Stakeholder Impact

• Shareholders may note the reduction in direct beneficial ownership by a director, which is a common data point for assessing insider sentiment.

Key Dates

Recommendation

The sale by a director, while reducing their direct holdings, was executed under a Rule 10b5-1 plan, suggesting a pre-planned liquidity event rather than a reaction to new material information. This transaction alone does not provide sufficient new information to alter a 'hold' recommendation for Ducommun Inc. stock.

Keywords

Ducommun, DCO, Insider Sale, Form 4, Richard A. Baldridge, Director, Stock Transaction, Rule 10b5-1